MRVIMaravai LifeSciences Holdings, Inc.

MRVI Stock Price, Valuation & Chart | Maravai LifeSciences Holdings, Inc.

Compare

$7.300-0.34 (-4.45%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology MRVI intrinsic value MRVI calculated fair value vs price

Overview Financials Dividends Ratios

MRVI Historical price chart

MRVI Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.02B

PE Ratio-38.42

EPS-0.19

Trading Volume2.70M

Today's High/Low7.59/7.28

Dividend Yield0.00

52 Week High/Low9.42/2.29

Shares Outstanding145.10M

MRVI Financial Statement

MRVI Analyst ratings

MRVI Analysis & performance metrics

MRVI Company profile

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research…

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications,…

MRVI Management team

Name

Position

Christopher C. Benoit

Executive Vice President & Advisor

Kurt Oreshack J.D.

Executive Vice President, General Counsel & Secretary

William E. Martin IIICEO

Chief Executive Officer & Director

Debra HartCTO

Senior Director of Investor Relations

Robert Andrew Eckert M.B.A., MBA

Chairman of the Board

Peter Michael Leddy Ph.D.

Executive Vice President & Chief Administrative Officer

Christine Dolan

Executive Vice President & GM of Cygnus Technologies

Kevin M. Herde CPACFO

Executive Vice President & Chief Financial Officer

Name

Position

Christopher C. Benoit

Executive Vice President & Advisor

Kurt Oreshack J.D.

Executive Vice President, General Counsel & Secretary

William E. Martin IIICEO

Chief Executive Officer & Director

Debra HartCTO

Senior Director of Investor Relations

Robert Andrew Eckert M.B.A., MBA

Chairman of the Board

Peter Michael Leddy Ph.D.

Executive Vice President & Chief Administrative Officer

Christine Dolan

Executive Vice President & GM of Cygnus Technologies

Kevin M. Herde CPACFO

Executive Vice President & Chief Financial Officer

Management Team

Christopher C. Benoit

Executive Vice President & Advisor

Kurt Oreshack J.D.

Executive Vice President, General Counsel & Secretary

William E. Martin IIICEO

Chief Executive Officer & Director

Debra HartCTO

Senior Director of Investor Relations

Robert Andrew Eckert M.B.A., MBA

Chairman of the Board

Peter Michael Leddy Ph.D.

Executive Vice President & Chief Administrative Officer

Christine Dolan

Executive Vice President & GM of Cygnus Technologies

Kevin M. Herde CPACFO

Executive Vice President & Chief Financial Officer

Management

Christopher C. Benoit

Executive Vice President & Advisor

Kurt Oreshack J.D.

Executive Vice President, General Counsel & Secretary

William E. Martin IIICEO

Chief Executive Officer & Director

Debra HartCTO

Senior Director of Investor Relations

Robert Andrew Eckert M.B.A., MBA

Chairman of the Board

Peter Michael Leddy Ph.D.

Executive Vice President & Chief Administrative Officer

Christine Dolan

Executive Vice President & GM of Cygnus Technologies

Kevin M. Herde CPACFO

Executive Vice President & Chief Financial Officer

Total 8 executives

MRVI Frequently asked questions

What is Maravai LifeSciences Holdings, Inc. (MRVI) Stock Price?

Current stock price of Maravai LifeSciences Holdings, Inc. (MRVI) stock is $7.300. The stock price is -4.45% lower in the session. The intraday range can be seen from this page. Volume of Maravai LifeSciences Holdings, Inc. (MRVI) stock is 2.70M.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Maravai LifeSciences Holdings, Inc. (MRVI) stock price going up or down today?

The stock price of Maravai LifeSciences Holdings, Inc. (MRVI) can change with earnings, company news, and overall market sentiment. Maravai LifeSciences Holdings, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Maravai LifeSciences Holdings, Inc. stock expensive at its current price?

Whether Maravai LifeSciences Holdings, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MRVI on this page is -38.42. EPS on this page is -0.19. Compare those figures with peers and growth expectations before deciding if the current Maravai LifeSciences Holdings, Inc. price is justified.

How has the stock price of Maravai LifeSciences Holdings, Inc. (MRVI) performed historically?

Historical performance for Maravai LifeSciences Holdings, Inc. (MRVI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MRVI reacted to past earnings and market events.

Should I buy Maravai LifeSciences Holdings, Inc. (MRVI) stock, at this price?

Buying Maravai LifeSciences Holdings, Inc. (MRVI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.